A single supratentorial high‐grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival-Reference-Cited by-同舟云学术

A single supratentorial high‐grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival

Published:2020-05-08 Issue:7 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Bremer Juliane¹²^ORCID,Kottke Raimund³,Johann Pascal D.⁴⁵⁶,Hoff Katja⁷,Brazzola Pierluigi⁸,Grotzer Michael A.⁹,Kool Marcel⁴⁵¹⁰,Rushing Elisabeth¹,Gerber Nicolas U.⁹

Affiliation:

1. Institute of Neuropathology University Hospital Zurich Zurich Switzerland

2. Institute of Neuropathology University Hospital RWTH Aachen Aachen Germany

3. Department of Diagnostic Imaging University Children's Hospital Zurich Zurich Switzerland

4. Hopp Children's Cancer Center (KiTZ) Heidelberg Germany

5. Division of Pediatric Neurooncology German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) Heidelberg Germany

6. Department of Pediatric Hematology and Oncology University Hospital Heidelberg Heidelberg Germany

7. Department of Pediatric Hematology and Oncology Charité University Medicine Berlin Germany

8. Istituto Pediatrico della Svizzera Italiana Bellinzona Switzerland

9. Department of Oncology University Children's Hospital Zurich Zurich Switzerland

10. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

Funder

Universität Zürich

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28384

Reference13 articles.

1. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

2. High‐grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication—a comprehensive clinical, radiographic, pathologic, and genomic analysis

3. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy

4. DNA methylation-based classification of central nervous system tumours

5. Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas;Acta Neuropathologica Communications;2024-04-05

2. Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?;Frontiers in Molecular Neuroscience;2024-03-13

3. Insights into the molecular roles of FOXR2 in the pathology of primary pediatric brain tumors;Critical Reviews in Oncology/Hematology;2023-12

4. A Radiologist’s Guide to the 2021 WHO Central Nervous System Tumor Classification: Part 2—Newly Described and Revised Tumor Types;Radiology;2023-06-01

5. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population;Acta Neuropathologica Communications;2023-02-13